§ Funding Round
Series C funding round for Oculis raising $57M in May 2021
Series C funding round for Oculis raising $57M in May 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Angel | zhi yang | |
| Organization | — | |
| Angel | kiersten stead | |
Dimension Capital | — | — |
| Organization | — | |
| Organization | — | |
EQT Life Sciences | — | — |
| Organization | — | |
| Organization | — | |
New Enterprise Associates (NEA) | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | farzad nazem | |
| Organization | — | |
| Organization | — | |
| Angel | dr. sylvia xin he | |
Nan Fung Life Sciences | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Wille Finance | — | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$297M
Top Valuation
-
Oculis raised $57M in a Series C round.
The round was announced on 05/01/21.
The round was led by bvcf (bioveda china fund), dr. sylvia xin he.
